Cardiovascular
Cardiovascular
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. They are developing a new standard for coronary artery disease by integrating the highest quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, they aim to provide a comprehensive solution for cardiovascular disease evaluation that offers the greatest value to the healthcare system and improves heart health for patients at risk of heart attacks.
Esperion's innovative Lipid Management Team is committed to leveraging its understanding of cholesterol biosynthesis to develop convenient, complementary, consistent, once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein (LDL-C). Their goal is lipid management for everybody, that’s why they work hard to make medicines accessible. They discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Positions are location-specific.
